Medico Remedies Limited

Medico Remedies Limited

Medico Remedies Limited has informed the Exchange about Book Closure Dates for its 32nd Annual General Meeting scheduled on September 22, 2026.

Medico Remedies Limited

Medico Remedies Limited has informed the Exchange regarding Notice of 32nd Annual General Meeting to be held on September 22, 2026.

Medico Remedies Limited

Medico Remedies Limited has announced its quarterly standalone financial results for the quarter ended June 30, 2026, along with the re-appointment of two directors, Mr. Rishit Mehta and Mr. Haresh Mehta, and an increase in remuneration for the Managing Director, Mr. Harshit Mehta.

Medico Remedies Limited

Medico Remedies Limited has secured a government supply order worth USD 1.40645 million from PROMESE/CAL, Dominican Republic, to supply tablets, capsules, and dry syrups. The order is expected to be completed within 3 months.

Medico Remedies Limited

Medico Remedies Limited has experienced significant price movement, prompting the exchange to request information from the company to ensure transparency and protect investor interests.

Medico Remedies Limited

Medico Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window is closed for all insiders, designated persons, and their immediate relatives from July 1, 2026, up to 48 hours post the declaration of unaudited financial results for the quarter ended June 30, 2026.

Medico Remedies Limited

Medico Remedies Limited has informed the Exchange about the reaffirmation of its credit ratings by CRISIL Ratings Limited for its long-term and short-term bank facilities.